We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Innovative 3-D Vessel Navigator for Treatment of Vascular Disease Launched

By MedImaging International staff writers
Posted on 05 May 2015
Image: Philips VesselNavigator (Photo courtesy of Philips Healthcare).
Image: Philips VesselNavigator (Photo courtesy of Philips Healthcare).
New, advanced visualization software that can be used with interventional X-Ray systems to help vascular surgeons guide catheters during treatment of vascular disease has been announced.

The vessel navigator fuses X-ray images of blood vessels with 3-D Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) images and creates 3-D color-coded images of the vessels. The navigator enables minimally invasive treatment of aortic aneurysms and has been shown to reduce contrast medium usage by up to 70% and vascular procedure duration by 18%.

The VesselNavigator was developed by Philips Healthcare (Best, The Netherlands) and was designed for use with Philips’ interventional X-ray systems. Vascular surgeons can use the VesselNavigator to maneuver a catheter, through major blood vessels using image guidance. The surgeon can then position and deploy stents or other implants to reinforce the vessel walls.

Prof. Dr. Frank Vermassen, Head of Vascular and Thoracic Surgery at University Hospital Ghent (Ghent, Belgium), said, “VesselNavigator gives vascular surgeons during endovascular procedures the 3D view of the patient’s anatomy, which they are familiar with from open surgery. It also significantly reduces the amount of contrast medium required, which means a lesser burden on the kidneys. And with a growing population of elderly and diabetic people who suffer from poor kidney function, reducing contrast medium requirements will open up endovascular treatments to a wider range of patients.”

Related Links:

Philips Healthcare
University Hospital Ghent


Post-Processing Imaging System
DynaCAD Prostate
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Mammography System (Analog)
MAM VENUS
Digital Color Doppler Ultrasound System
MS22Plus

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.